Literature DB >> 16537995

Differences in the neuronal stem cells survival, neuronal differentiation and neurological improvement after transplantation of neural stem cells between mild and severe experimental traumatic brain injury.

Tokuhisa Shindo1, Yoshihito Matsumoto, Qinghua Wang, Nobuyuki Kawai, Takashi Tamiya, Seigo Nagao.   

Abstract

We developed a novel protocol for generation and selective amplification of neural progenitor cells regionally specified to the rostral brain but not the spinal cord from mouse embryonic stem cells (ESCs). The neural progenitors could differentiate in vitro and in vivo into many cholinergic and a few GABAergic neurons but rarely into astrocytes. The transplanted neurospheres could survive in the hippocampus (CA3) of animals with mild traumatic brain injury (TBI). Twelve weeks after transplantation (a week after the behavioral test), we found significant cholinergic differentiation recognized as ChAT immunoreactivity in the eGFP+transplanted cells. Moreover, the grafts contained a few GAD67+cells. However, we barely found GFAP+astrocytes within the grafts. Furthermore, presynaptic formations of graft-derived neurons were recognized by immunohistochemistry of near the grafts around CA3. However, these findings were not observed in severe TBI group. So, we examined NGF, BDNF, and FGF-2 mRNA by RT-PCR in 12 mice including normal, mild TBI and severe TBI group. Increases in the neurotrophic factors' mRNA were evident in the hippocampus on the ipsilateral side in the mild TBI group. Statistical analysis revealed significant differences between the mild and severe TBI groups. The data also revealed significant differences between the mild TBI and normal groups. The transplanted neurospheres could survive in the mild TBI animals, but not in the severe TBI group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537995     DOI: 10.2152/jmi.53.42

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  24 in total

1.  Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF.

Authors:  Soshana Behrstock; Allison D Ebert; Sandra Klein; Melanie Schmitt; Jeannette M Moore; Clive N Svendsen
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

Review 2.  Stem cell therapy for neurological disorders: A focus on aging.

Authors:  Hung Nguyen; Sydney Zarriello; Alexandreya Coats; Cannon Nelson; Chase Kingsbury; Anna Gorsky; Mira Rajani; Elliot G Neal; Cesar V Borlongan
Journal:  Neurobiol Dis       Date:  2018-09-13       Impact factor: 5.996

3.  Human Neural Stem/Progenitor Cells Derived From Epileptic Human Brain in a Self-Assembling Peptide Nanoscaffold Improve Traumatic Brain Injury in Rats.

Authors:  Ali Jahanbazi Jahan-Abad; Sajad Sahab Negah; Hassan Hosseini Ravandi; Sedigheh Ghasemi; Maryam Borhani-Haghighi; Walter Stummer; Ali Gorji; Maryam Khaleghi Ghadiri
Journal:  Mol Neurobiol       Date:  2018-04-12       Impact factor: 5.590

4.  Treatment of traumatic brain injury in mice with marrow stromal cells.

Authors:  Changsheng Qu; Asim Mahmood; Dunyue Lu; Anton Goussev; Ye Xiong; Michael Chopp
Journal:  Brain Res       Date:  2008-03-04       Impact factor: 3.252

5.  Analysis of human embryonic stem cells with regulatable expression of the cell adhesion molecule l1 in regeneration after spinal cord injury.

Authors:  Myungsik Yoo; Gunho Anthony Lee; Christopher Park; Rick I Cohen; Melitta Schachner
Journal:  J Neurotrauma       Date:  2014-03-15       Impact factor: 5.269

Review 6.  Current challenges for the advancement of neural stem cell biology and transplantation research.

Authors:  Kristien Reekmans; Jelle Praet; Jasmijn Daans; Veerle Reumers; Patrick Pauwels; Annemie Van der Linden; Zwi N Berneman; Peter Ponsaerts
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

Review 7.  Developments in intracerebral stem cell grafts.

Authors:  Stephanny Reyes; Naoki Tajiri; Cesar V Borlongan
Journal:  Expert Rev Neurother       Date:  2015-03-05       Impact factor: 4.618

Review 8.  Cell therapies for traumatic brain injury.

Authors:  Matthew T Harting; James E Baumgartner; Laura L Worth; Linda Ewing-Cobbs; Adrian P Gee; Mary-Clare Day; Charles S Cox
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

9.  Subacute neural stem cell therapy for traumatic brain injury.

Authors:  Matthew T Harting; Leeann E Sloan; Fernando Jimenez; James Baumgartner; Charles S Cox
Journal:  J Surg Res       Date:  2008-04-23       Impact factor: 2.192

10.  Acute, regional inflammatory response after traumatic brain injury: Implications for cellular therapy.

Authors:  Matthew T Harting; Fernando Jimenez; Sasha D Adams; David W Mercer; Charles S Cox
Journal:  Surgery       Date:  2008-08-10       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.